在比沙的孕产妇糖尿病和新生儿结果:回顾性队列研究
Abdullah Alshomrany1, Elhadi Miskeen2, Jaber Alfaifi3
1College of Medicine, University of Bisha, Bisha 67714, Saudi Arabia.
Medical sciences (Basel, Switzerland)
|April 23, 2024
概括
在沙特阿拉伯比沙市,孕产妇糖尿病 (MDM) 增加了新生儿的风险. 早期识别和管理MDM对于改善婴儿健康结果和降低死亡率至关重要.
科学领域:
- 产科和妇科 产科和妇科
- 新生儿科学 新生儿科学
- 公共卫生 公共卫生
背景情况:
- 孕产妇糖尿病 (MDM) 是全球新生儿不良结果的已知危险因素.
- 沙特阿拉伯比沙市MDM对新生儿健康的具体影响仍未充分记录.
研究的目的:
- 在沙特阿拉伯比沙的产妇和儿童医院 (MCH) 调查母亲糖尿病和新生儿结局之间的关联.
- 确定该地区与MDM相关的特定不良新生儿结局.
主要方法:
- 一项回顾性队列研究,涉及181名患有糖尿病的孕妇及其新生儿.
- 从2020年10月到2022年11月在MCH,Bisha.收集的数据.
- 使用后勤回归分析来评估MDM对新生儿不良结果的综合影响,并对混因素进行调整.
主要成果:
- 患有MDM的母亲产生的新生儿表现出明显更高的不良结果风险 (aOR = 1.46).
- 观察到对巨 (aOR = 1.74),低出生体重 (aOR = 1.32) 和呼吸困扰综合征 (aOR = 1.57) 的风险增加.
- 特定的糖尿病类型与低血糖症,巨和新生儿死亡有显著的相关性.
结论:
- 孕产妇糖尿病与比沙的新生儿不良结果增加有显著的关联.
- 及时识别和有效管理MDM对于减轻新生儿发病率和死亡率至关重要.
- 这项研究强调了沙特阿拉伯糖尿病孕妇有针对性的干预措施的必要性.
相关概念视频
Pathophysiology of Diabetes
922
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
922
Diabetes Mellitus: Type 2 and Gestational
2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
Diabetes Mellitus: Overview and Type I Subtype
2.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K
Diabetes: Symptoms, Diagnosis, and Complications
526
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
526
Inborn Errors of Metabolism
157
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
157
Teratogenicity
2.4K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.4K


